RT Journal Article
SR Electronic
A1 Cunningham, Muriel
T1 TAVR Decreases Mortality When Compared with Surgery in High-Risk Patients
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 4
SP 13
OP 13
DO 10.1177/155989771404002
UL http://mdc.sagepub.com/content/14/4/13.abstract
AB A large, prospective, randomized trial was conducted at 45 sites in the United States to compare the safety and efficacy of transcatheter aortic valve replacement (TAVR) with the CoreValve self-expanding prosthesis with surgical aortic-valve replacement (SAVR) in patients with severe aortic stenosis at high risk for cardiac surgery. This article presents the results from the patients in the high-risk cohort who were randomized to either CoreValve or surgery [Adams DH et al. N Engl J Med 2014].